Cogent Biosciences Q2 EPS $(0.52) Beats $(0.57) Estimate

Cogent Biosciences (NASDAQ:COGT) reported quarterly losses of $(0.52) per share which beat the analyst consensus estimate of $(0.57) by 8.77 percent. This is a 1.89 percent increase over losses of $(0.53) per share from the same period last year.